WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 406264
CAS#: 1355326-35-0
Description: AGI-5198, also know as IDH-C35, is the a very potent and selective mutant IDH1 inhibitor that was shown to potential anticancer activity. AGI-5198 shows good potency in the U87 R132H cell based assay and ~90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing. AGI-5198 inhibits IDH1 R132H mutant and R132C mutant in vitro with IC50 ~0.07 μM and ~0.16 μM, respectively.
MedKoo Cat#: 406264
Name: AGI-5198
CAS#: 1355326-35-0
Chemical Formula: C27H31FN4O2
Exact Mass: 462.2431
Molecular Weight: 462.55904
Elemental Analysis: C, 70.11; H, 6.76; F, 4.11; N, 12.11; O, 6.92
Synonym: AGI5198; AGI-5198; AGI 5198; IDHC35; IDH-C35; IDH C35.
IUPAC/Chemical Name: N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide
InChi Key: FNYGWXSATBUBER-UHFFFAOYSA-N
InChi Code: InChI=1S/C27H31FN4O2/c1-19-9-6-7-14-24(19)26(27(34)30-22-11-4-3-5-12-22)32(23-13-8-10-21(28)17-23)25(33)18-31-16-15-29-20(31)2/h6-10,13-17,22,26H,3-5,11-12,18H2,1-2H3,(H,30,34)
SMILES Code: O=C(NC1CCCCC1)C(N(C2=CC=CC(F)=C2)C(CN3C=CN=C3C)=O)C4=CC=CC=C4C
ML-309 , a Me-Too version of AGI-5198 is recently added in our website. Their chemical structures are compared side-by-side as the following:
1: Kim J, DeBerardinis RJ. Cancer. Silencing a metabolic oncogene. Science. 2013 May 3;340(6132):558-9. doi: 10.1126/science.1238523. PubMed PMID: 23641103.
